Filing Details

Accession Number:
0001193805-23-001317
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-22 21:21:02
Reporting Period:
2023-09-20
Accepted Time:
2023-09-22 21:21:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1262104 Mei Pharma Inc. MEIP Pharmaceutical Preparations (2834) 510407811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1491069 Ross Bruce Winson 16000 Dallas Parkway
Suite 800
Dallas TX 75248
No No Yes No
1491072 Anson Funds Management Lp 16000 Dallas Parkway
Suite 800
Dallas TX 75248
No No Yes No
1491073 Anson Management Gp Llc 16000 Dallas Parkway
Suite 800
Dallas TX 75248
No No Yes No
1581079 Anson Advisors Inc. 155 University Avenue
Suite 207
Toronto A6 M5H 3B7
No No Yes No
1585167 Moez Kassam 111 Peter Street
Suite 904
Toronto A6 M5V2H1
No No Yes No
1962354 Amin Nathoo 155 University Avenue
Suite 207
Toronto Z4 M5H 3B7
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-20 120,000 $6.01 782,528 No 4 P Indirect See footnotes
Common Stock Acquisiton 2023-09-21 33,600 $6.46 816,128 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
No 4 P Indirect See footnotes
Footnotes
  1. The filing of this Form 4 shall not be construed as an admission that Anson Funds Management LP ("Anson"), Anson Management GP LLC, the general partner of Anson ("Anson GP"), Bruce R. Winson, the manager of Anson GP, Anson Advisors Inc. ("Anson Advisors"), Amin Nathoo, a director of Anson Advisors, or Moez Kassam, a director of Anson Advisors, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the shares of Common Stock, $0.00000002 par value (the "Common Stock"), of MEI Pharma, Inc. (the "Issuer") purchased by Anson Investments Master Fund LP, Anson East Master Fund LP and Anson Opportunities Master Fund LP (collectively, the "Funds"), each advised by Anson and Anson Advisors.
  2. Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
  3. Anson and Anson Advisors hold indirectly 816,128 shares of Common Stock of the Issuer through the Funds, for which Anson and Anson Advisors are the Investment Advisors. Anson GP and Bruce R. Winson report the Common Stock held indirectly by the Funds because, as the general partner of Anson and the manager of Anson GP, respectively, at the time of purchase, they controlled the disposition and voting of the securities. Mr. Nathoo and Mr. Kassam report the Common Stock held indirectly by the Funds because, as the directors of Anson Advisors, at the time of purchase, they controlled the disposition and voting of the securities.